Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered
Xconomy Boston — Gene editing biotech Beam Therapeutics raised $180 million in its initial public offering Wednesday after offering 48...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page